Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction.

MLA

Suzuki, Hideaki, et al. “Evaluating Haemodynamic Changes: Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction.” ESC Heart Failure, vol. 11, no. 4, Aug. 2024, pp. 2451–54. EBSCOhost, https://doi.org/10.1002/ehf2.14802.

APA

Suzuki, H., Inoue, T., Terui, Y., Takeuchi, K., Susukita, K., Arai, M., Sato, H., Satoh, T., Yamamoto, S., Yaoita, N., Tatebe, S., Hayashi, H., Nochioka, K., Takahama, H., & Yasuda, S. (2024). Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 11(4), 2451–2454. https://doi.org/10.1002/ehf2.14802

Chicago

Suzuki, Hideaki, Takumi Inoue, Yousuke Terui, Kouki Takeuchi, Kai Susukita, Marina Arai, Haruka Sato, et al. 2024. “Evaluating Haemodynamic Changes: Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction.” ESC Heart Failure 11 (4): 2451–54. doi:10.1002/ehf2.14802.